23 Jul, 2026
The global urinary drainage bags market size reached USD 2.26 billion in 2025 and is anticipated to grow from USD 2.35 billion in 2026 to USD 3.21 billion by 2034, expanding at a CAGR of 4% over the forecast period from 2026 to 2034.
Urinary drainage bags contain and collect uncontrolled urine in people with urological problems. Urine drainage bags are also used to monitor urine output. By attaching the catheter line to a urine drainage bag, urine can be collected. The urethra, the body's exit point for urine, puts the urinary catheter into the bladder. Numerous other urinary drainage bags are available, including leg, large, reusable, and disposable bags.
Urine collection is commonly done with the use of large bags that are attached to the leg while sleeping. Comfort is increased by the leg pouch, which is hidden by garments. Urine drainage bags must be cleaned and emptied to maintain urine flow and stop reflux. Their widespread use in several hospitals and healthcare facilities has increased their demand.
As urological illnesses such as urine retention, cystitis, benign prostatic hyperplasia, urinary incontinence, and kidney stones—which lead to bladder dysfunction—become more prevalent, it is predicted that the global market for urinary drainage bags will expand. Urinary drainage bags must be used to collect urine in patients with urinary incontinence (UI), one of the most prevalent medical conditions, especially those bedridden and with limited mobility. UI is a condition that is quite common all around the world. Stress symptoms, including coughing, sneezing, and laughing, might worsen with age, during pregnancy, childbirth, and in situations of obesity.
In addition, those who have enlarged prostates, multiple sclerosis, Parkinson's disease, cerebrovascular accidents, or spinal cord illnesses need urine drainage bags due to long-term bladder retention. The need for urine drainage bags for post-operative convenience has increased due to the growing prevalence of urological dysfunctions and associated procedures. Throughout the projection period, this is anticipated to have a favorable effect on market growth.
The presence of several e-commerce sites that offer services for urinary drainage bags may help boost sales of the products through this sales channel. Product penetration through online networks is rapidly expanding because customers may assess and select the finest products based on their brand, kind, price, and location of sale. Several well-known e-commerce sites, including Amazon, Clinisupplies, Vitality Medical, Shop Catheters, Nightingale (Great Bear Healthcare), and Express Medical Supply Inc., provide significant discounts and prompt customer service on various urine bags. These online stores provide access to special discounts, a return policy if the product doesn't meet the customer's expectations, and a product guarantee with product help. Therefore, it is projected that the simple availability of numerous urinary drainage bags online would fuel the market rise.
North America is the most significant global urinary drainage bags market shareholder and is estimated to grow at a CAGR of 3.7% over the forecast period. The market for urinary drainage bags in North America is mostly driven by the incidence of urological diseases such as bladder cancer, urine retention, obstruction from benign prostate hyperplasia (BPH), and urinary incontinence (UI). For instance, the American Academy of Family Physicians (AAFP) estimates that more than 250,000 BPH patients undergo surgery yearly. According to the Canadian Cancer Society, around 12,200 people were diagnosed with bladder cancer in 2020, and 2,600 died. As a result, rising BPH-related surgical procedures and bladder cancer incidences drive the market for urinary drainage bags in North America.
Europe is anticipated to exhibit a CAGR of 3.5% over the forecast period. Expanding older populations, growing urological disease incidence, and improved awareness among European nations are a few factors anticipated to drive this market. The European Institute of Women's Health states that UI is a prevalent, disabling condition that affects 10% to 20% of women in Europe. The same source estimates that 60 million UI diagnoses were made in Europe in 2016. Additionally, between 25% and 45% of women are anticipated to acquire UI in their lifetime, making them twice as likely as men to do so. Additionally, organizations like the European Association of Urological are developing numerous recommendations to raise public knowledge of urological disorders like UI.
sales@straitsresearch.com